Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

11

Full text

9

Free full text

3

Publication Types

Journal Article

11

Review

6

Research Support, Non-U.S. Gov't

4

Research Support, N.I.H., Extramural

3

Comparative Study

1

Research Support, U.S. Gov't, Non-P.H.S.

1

Research Support, U.S. Gov't, P.H.S.

1

Clinical Trial

1

Randomized Controlled Trial

1

Controlled Clinical Trial

1

Publication Year

From

To

Quick links

Individual year

2023

2

2021

1

2017

1

2013

2

2005

2

2003

1

2002

1

2001

1

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Dynorphins""[mesh_terms]

11 Results

Searching titles within these results

Dynorphin 1-17 biotransformation peptides: properties, challenges and solutions for future therapeutics development.

Siti Sarah Fazalul Rahiman, Noratiqah Mohtar, Salizawati Muhamad Salhimi, Rama Ballouze

Future medicinal chemistry 2023;15(9):791-808

Emerging Role of DREAM in Healthy Brain and Neurological Diseases.

Lucio Annunziato, Rossana Sirabella, Valeria Valsecchi, Antonella Casamassa, Luca Sanguigno, Pasquale Molinaro, Giuseppe Pignataro, Luigi Formisano

International journal of molecular sciences 2023;24(11):9177

Endogenous dynorphins, glutamate and N-methyl-d-aspartate (NMDA) receptors may participate in a stress-mediated Type-I auditory neural exacerbation of tinnitus.

Tony L Sahley, Michael D Hammonds, Frank E Musiek

Brain research 2013;1499():80-108

Separation of dynorphin peptides by capillary electrochromatography using a polydiallyldimethylammonium chloride gold nanoparticle-modified capillary.

Abdullah M Al-Hossaini, Leena Suntornsuk, Susan M Lunte

Electrophoresis 2017;37(17-18):2297-304

Opioid-modulating peptides: mechanisms of action.

Jean-Marie Zajac, Michel Roumy, Catherine Mollereau

Current topics in medicinal chemistry 2005;5(3):341-55

Nardilysin in human brain diseases: both friend and foe.

H-G Bernstein, R Stricker, H Dobrowolny, J Steiner, B Bogerts, K Trübner, G Reiser

Amino acids 2013;45(2):269-78

beta-Endorphin modulation of pressor response to hyperventilation in hypertensive patients.

Fiorella Fontana, Pasquale Bernardi, Santi Spampinato, Rosanna Di Toro, Raffaele Bugiardini

Peptides 2003;23(5):911-8

Pharmacological characterization of human kappa/mu opioid receptor chimeras that retain high affinity for dynorphin A.

Robert N DeHaven, Erik Mansson, Jeffrey D Daubert, Joel A Cassel

Current topics in medicinal chemistry 2005;5(3):303-13

p53 Latency. C-terminal domain prevents binding of p53 core to target but not to nonspecific DNA sequences.

T Yakovleva, A Pramanik, T Kawasaki, K Tan-No, I Gileva, H Lindegren, U Langel, T J Ekstrom, R Rigler, L Terenius, G Bakalkin

The Journal of biological chemistry 2001;276(19):15650-8

Substance P and calcitonin gene-related peptide increase IL-1 beta, IL-6 and TNF alpha secretion from human peripheral blood mononuclear cells.

M C Cuesta, L Quintero, H Pons, H Suarez-Roca

Neurochemistry international 2002;40(4):301-6

Assessment of stress markers in restrained individuals following physical stress with and without sham CED activation.

Daniel Lasoff, Gabriel Wardi, Edward M Castillo, Tom Neuman, Fred Kolkhorst, Christian Sloane, Deborah C Mash, Theodore C Chan, Gary M Vilke, Xiaobin Xie

Journal of forensic and legal medicine 2021;74():101982

Results: 1 – 11 / 11

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.